NCT02690168View on ClinicalTrials.gov

Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 27, 2017

Study Completion Date

July 31, 2017

Conditions
Diabetes ComplicationsHypoglycemia
Interventions
BEHAVIORAL

Fasting

72 hour fasting

Trial Locations (1)

70808-4124

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
lead

Pennington Biomedical Research Center

OTHER

NCT02690168 - Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy | Biotech Hunter | Biotech Hunter